The Effects of Anodal tDCS on Incontinency in Patients with Multiple Sclerosis (MS)

INTERVENTION: Intervention 1: Intervention group: Anodal tDCS over M1 cortex concurrent group with progressive exercises of pelvic floor muscles. Intervention 2: Intervention group: Anodal sham tDCS over M1 cortex concurrent group with progressive exercises of pelvic floor muscles. CONDITION: Multiple sclerosis. ; Multiple sclerosis PRIMARY OUTCOME: Level of urinary incontinence. Timepoint: Before the intervention, 4 and 6 weeks after the start of intervention and one month after the end of intervention. Method of measurement: International Consultation on Incontinence Questionnaire‐Urinary Incontinence Short Form. Pelvic floor muscle function. Timepoint: Before the intervention, 4 and 6 weeks after the start of intervention and one month after the end of intervention. Method of measurement: ultrasonographic device. INCLUSION CRITERIA: Women with Definitive Diagnosis of MS with Stable Disease over the Previous 4 Months Definite MS Diagnosis According to the 2010 Revised McDonald Criteria Age Is Between 18 and 45 Years Having Symptoms of Urinary Incontinence Patients Have Received Stable Pharmacological Therapies for the Past 6 Months Patient's Expanded disability status scale (EDSS) Score Should Be Less than 6.5 Patients Have the Cognitive Capacity to Complete the Assessment and Treatment Protocol Minimal Ability to Contract the Pelvic Floor Muscles To Be Willing to Participate in the Study